OBJECTIVE. The goal of this study was to show that one can safely remove al
l sonographic evidence of masses in the breast less than or equal to 1.5 cm
in greatest dimension using the 11-gauge handheld Mammotome, thereby reduc
ing the possibility of a false-negative diagnosis and other shortcomings of
the automated core biopsy device.
SUBJECTS AND METHODS. Over a 12-week period (May 3-July 31, 2000), 124 sono
graphically guided breast biopsies were performed in 113 patients, using a
new handheld directional vacuum-assisted biopsy device. All lesions that: w
ere less than or equal to 1.5 cm were biopsied using a handheld Mammotome;
an attempt was made to continue the biopsy until no sonographic evidence of
the lesion remained.
RESULTS. Of these 124 lesions, 14 had infiltrating ductal carcinomas, four
had infiltrating ductal carcinomas with associated ductal carcinoma in situ
, one had infiltrating lobular carcinoma, one had ductal carcinoma in situ,
three had atypical ductal hyperplasias, one had atypical lobular hyperplas
ia, and one had phyllodes tumor. Only one infiltrating ductal carcinoma was
entirely removed histologically at Mammotome biopsy. There were no underes
timates of disease. No cases of epithelial displacement were observed in an
y of the surgical excisions of malignancies. The remaining 99 lesions were
benign.
CONCLUSION. The handheld Mammotome diminishes the shortcomings of the autom
ated core biopsy device. It reduces the possibility of false-negatives and
underestimation of disease. It eliminates the need for multiple insertions
and reduces the likelihood of epithelial displacement. As a result, we now
use this device for all sonographically guided biopsies of breast masses sm
aller than 1.5 cm and recommend that others consider it for such use.